课题基金 / 基金详情

Genetic analysis of glomerular podocyte molecules in children with nephrotic syndrome

Genetic analysis of glomerular podocyte molecules in children with nephrotic syndrome
肾病综合征患儿肾小球足细胞分子的遗传分析
批准号:
18591199
负责人:
YOSHIKAWA Norishige
金额:
$2.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

YOSHIKAWA Norishige的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Podocin is an integral membrane protein encodedby NPHS2, which is mapped to 1q25-31 and exclusively expressed in glomerular podocytes. NPHS2 mutations are responsible for autosomal recessive familial steroid-resistant nephrotic syndrome (SRNS). It has been demonstrated that sporadic SRNS and steroid-sensitive nephrotic syndrome. We isolated genomic DNA from 26 Japanese children with steroid-resistant nephrotic syndrome and 45 Japanese children with steroid-sensitive nephrotic syndrome. We analyzed all eight exons of NPHS2 using the polymerase chain reaction and direct sequencing. Four silent variants (102G>A, 288C>T, 954T>C, 1038A>G) were identified in some of the patients and normal controls, indicating that the silent variants are polymorphisms. There was nosignificant difference in the genotypic and allelic frequencies of these 4 polymorphisms between the patients and normal controls and between the steroid-resistant and steroid-sensitive patients. In conclusion, NPHS2 gene mutations are not a major cause of nephrotic syndrome in Japanese children.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effective and safe treatment with cyclosporine in nephritic children:a prospective,randomized,multicenter trial.
环孢素治疗肾病儿童有效且安全:一项前瞻性、随机、多中心试验。
DOI: --
发表时间: 2008
期刊: Kidney Int 73
影响因子: --
作者: [Nozu, K., Inagaki, T., Fu, XZ., Nozu, Y., Kaito, H., Kanda, K., Sekine, T., Igarashi, I., Nakanishi, K., Yoshikawa, N., Iijima, K., Matsuo, M, Nozu K, Yata N, Yoshikawa N, Ishikura N]
通讯作者: Ishikura N
Effective and safe treatment with cyclosporine in nephritic children:a prospective,randomized,multicenter trial
环孢素治疗儿童肾病有效且安全:一项前瞻性、随机、多中心试验
DOI: --
发表时间:
期刊: Kidney Int (In Press)
影响因子: --
作者: [CattranDC, Alexopoulos, E., Heeling, P., Hoyer, PF., Johnston, A., Meyrier, A., Ponticelli C, Saito T, Choukroun, G., Nachman, P., Praga, M., Yoshikawa, N, Kamioka I, Nozu K, Fujita T, CattranDC, Fujita T, Nozu K, Yoshikawa N, Obana M, Kaito H, Yata N, Yoshikawa N, Ishikura K]
通讯作者: Ishikura K
Kidney Disorders in Children and Adolescents A Global Perspective of Clinical Pracice
儿童和青少年肾脏疾病临床实践的全球视角
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Ishikura, K., Ikeda, M., Hattori, S., Yoshikawa, N., Sasaki, S., Iijima, K., Nakanishi, K., Yata, N., Honda, M, Yoshikawa N]
通讯作者: Yoshikawa N
DOI: 10.2215/cjn.01120905
发表时间: 2006-05-01
期刊: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
影响因子: 9.8
作者: [Yoshikawa, Norishige, Honda, Masataka, Ito, Hiroshi]
通讯作者: Ito, Hiroshi
20
    Role of imflammasome in IgA nephropathy
    • 批准号:
      24390265
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2012
    • 负责人:
      YOSHIKAWA Norishige
    • 依托单位:
    Mutation analysis in Japanese patients with congenital and infantile nephritic syndrome
    • 批准号:
      21591396
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2009
    • 负责人:
      YOSHIKAWA Norishige
    • 依托单位:
    Genetic analysis in children with Escherichia coli O157-associated hemolytic uremic syndrome
    • 批准号:
      15590855
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2003
    • 负责人:
      YOSHIKAWA Norishige
    • 依托单位:
    Platelet-activating factor acetylhydrolase gene mutation in Japanese children with Escherichia coli O157-associated hemolytic uremic syndrome
    • 批准号:
      12671039
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      2001
    • 负责人:
      YOSHIKAWA Norishige
    • 依托单位:
    海外基金